CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

doi:10.1002/jcla.20346

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

Journal of clinical laboratory analysis - 1 Jan 2009

de Oliveira Karen Brajão, Oda Julie Massayo Maeda, Voltarelli Julio Cesar, Nasser Thiago Franco, Ono Mario Augusto, Fujita Thiago Cezar, Matsuo Tiemi, Watanabe Maria Angelica Ehara

Abstract excerpt

Chemokines and their receptors regulate the trafficking of immune cells during their development, inflammation, and tissue repair. The single-nucleotide polymorphism (SNP) rs1801157 (previously known as CXCL12-A/ stromal cell-derived factor-1 (SDF1)-3'A) in CXCL12/SDF1 gene was assessed in breast cancer, Hodgkin's lymphoma (HL), and non-Hodgkin's lymphoma (NHL), since the chemokine CXCL12, previously known as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Case-Control Studies

Share to Chemokine CXCL12

Share to Gene Frequency

Share to Hodgkin Disease

Share to Lymphoma, Non-Hodgkin

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 19927352
DOI: 10.1002/jcla.20346
PMCID: PMC6649101

Genes

CXCL12
CXCR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.PMID 19927352Read ↗

CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.Semantic proximity Read ↗

Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.Semantic proximity Read ↗

Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study.Semantic proximity Read ↗

CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma: Is it associated with poor outcome?Semantic proximity Read ↗

Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.Semantic proximity Read ↗

Gene Variations of Chemokine and Chemokine Receptor CXCL12/CXCR4 in Lung Cancer.Semantic proximity Read ↗

CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.Semantic proximity Read ↗

CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma.Semantic proximity Read ↗

The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.Semantic proximity Read ↗

Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.Semantic proximity Read ↗

Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.